DRKS00015079
Completed
N/A
A prospective, non-interventional study to investigate the effectiveness of a recombinant fusion protein linking coagulation Factor IX with recombinant albumin (rIX-FP) in patients with hemophilia B
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- D67
- Sponsor
- CSL Behring GmbH
- Enrollment
- 73
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Factor IX deficiency.
- •Treatment with IDELVION® according to routine practice and according to the current SmPC (The decision for IDELVION® therapy was made independent of this NIS)
- •Written and personally dated informed consent of the patient or in case of minors of one parent or legal guardian after receiving detailed information about the observational study by the treating physician. Minors should also sign the informed consent, if his/her age allows it.
Exclusion Criteria
- •Existing inhibitor development.
- •Existing multi\-factor\-deficiency
- •simultaneous participation in an interventional study
- •Known hypersensitivity to any ingredient of the FIX product or hamster protein
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
A non-interventional, prospective study to evaluate change in physical activity, relationship satisfaction and psychological well-being in patients with rheumatoid arthritis after introduction of the JAK inhibitor filgotinib and also in their partners.M06.8Other specified rheumatoid arthritisDRKS00032128Helios Fachklinik Vogelsang-Gommern, Rheumatologie40
Active, Not Recruiting
N/A
A prospective non-interventional study to evaluate the effect of Triptorelin Embonate (Diphereline (Trademark TM) 11.25mg) on lower urinary tract symptoms (LUTS) in Australian prostate cancer patients.ocally advanced or metastatic prostate cancer with Lower Urinary Tract Symptoms (LUTS)Locally advanced or metastatic prostate cancer with Lower Urinary Tract Symptoms (LUTS)Cancer - ProstateRenal and Urogenital - Other renal and urogenital disordersACTRN12610000558022Ipsen Pty Ltd70
Completed
N/A
A Prospective, Non-Interventional Study to investigate the Effectiveness of AFSTYLA® in Patients with Hemophilia AD66Hereditary factor VIII deficiencyDRKS00017369CSL Behring GmbH52
Completed
N/A
A retrospective non-interventional study evaluating retention rate of Everolimus as add-on epilepsy therapy in adult patients with tuberose sclerosisQ85.1Tuberous sclerosisDRKS00020248Epilepsiezentrum Kork45
Not Yet Recruiting
Phase 2
Study of an Ayurveda regimen in COVID Positive patientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/07/026602Deenanath Mangeshkar Hospital Research Centre